Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
Jiao Li, Min Sun, Xiaodong Cui, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10020-10020
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 129
Royal Jelly: Biological Action and Health Benefits
Nada Oršolić, Maja Jazvinšćak Jembrek
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6023-6023
Open Access | Times Cited: 19
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer's disease
Yinghong Li, Ying Han, Qi Shu, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117814-117814
Open Access | Times Cited: 2
Alzheimer’s Disease Diagnosis Using Machine Learning: A Survey
Omer Asghar Dara, José Manuel López-Guede, Hasan Issa Raheem, et al.
Applied Sciences (2023) Vol. 13, Iss. 14, pp. 8298-8298
Open Access | Times Cited: 28
Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases
Stanley I.R. Okoduwa, Ibrahim Abdulwaliyu, Bernard E. Igiri, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100558-100558
Open Access | Times Cited: 13
Synthesis, biological activity, X-ray crystallographic, DFT calculations and molecular dynamics simulation studies of 2-phenylthiazole-1,3,5-triazine derivatives as potential cholinesterase inhibitors
Jing‐Pei Zou, Xiao. Qing Zhang, Qian. Wen Guo, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138203-138203
Closed Access | Times Cited: 8
Phytomedicine Potential of Oroxylum indicum Root and Its Constituents: Targeting Alzheimer’s Disease
Rattana Summat, Pornthip Waiwut, Supawadee Daodee, et al.
Plants (2025) Vol. 14, Iss. 2, pp. 223-223
Open Access | Times Cited: 1
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025) Vol. 569, pp. 161-183
Closed Access | Times Cited: 1
Exploring the anti-amyloid potential of salvianolic acid A against the ALS-associated mutant SOD1: insights from molecular docking and molecular dynamic simulations
Zainab Abdullah Waheed, Bagher Seyedalipour, Abasalt Hosseinzadeh Colagar, et al.
Molecular Simulation (2024) Vol. 50, Iss. 13, pp. 899-917
Closed Access | Times Cited: 7
The neuroprotective effect of ginsenoside Rb1 on the cerebral cortex changes induced by aluminium chloride in a mouse model of Alzheimer's disease: A histological, immunohistochemical, and biochemical study
Amany Mohamed Shalaby, Sulaiman Mohammed Alnasser, Dina Ahmed Khairy, et al.
Journal of Chemical Neuroanatomy (2023) Vol. 129, pp. 102248-102248
Closed Access | Times Cited: 13
Extracts of Sideritis scardica and Clinopodium vulgare Alleviate Cognitive Impairments in Scopolamine-Induced Rat Dementia
Maria Lazarova, Elina Tsvetanova, Almira Georgieva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1840-1840
Open Access | Times Cited: 5
Discovering the therapeutic potential of Naringenin in diabetes related to GLUT4 and its regulatory factors: a computational approach
Ali Khakpour, Shamim Ghiabi, Ali Kazemi Babaheydari, et al.
Chemical Physics Impact (2024), pp. 100784-100784
Open Access | Times Cited: 5
Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation
Seyed Mostafa Noorbakhsh Varnosfaderani, Melika Sadat Haeri, Ali Sam Arian, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-18
Closed Access | Times Cited: 12
Thiacalixarene Carboxylic Acid Derivatives as Inhibitors of Lysozyme Fibrillation
Anastasia Nazarova, Igor Shiabiev, K. S. Shibaeva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4721-4721
Open Access | Times Cited: 4
Utilising single‐cell sequencing in clinical nutraceutical research: Recent progress and perspectives
Xiaoqiang Wang, Yin Chan, David Sadava, et al.
Clinical and Translational Discovery (2025) Vol. 5, Iss. 1
Open Access
Alzheimer’s Prediction Methods with Harris Hawks Optimization (HHO) and Deep Learning-Based Approach Using an MLP-LSTM Hybrid Network
Raheleh Ghadami, Javad Rahebi
Diagnostics (2025) Vol. 15, Iss. 3, pp. 377-377
Open Access
Phytomolecules as Alzheimer’s Therapeutics: A Comprehensive Review
Mohd Kamil Hussain, Mafaz Ahmad, Shahnaaz Khatoon, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117401-117401
Closed Access
Discovery of effective GSK-3β inhibitors as therapeutic potential against Alzheimer's disease: A computational drug design insight
Fatemeh Sadat Seyedi Asl, Nasrin Malverdi, Fatemeh Mojahedian, et al.
International Journal of Biological Macromolecules (2025), pp. 141273-141273
Closed Access
Flavonoids and their role in oxidative stress, inflammation, and human diseases
Klaudia Jomová, Suliman Yousef Alomar, Richard Valko, et al.
Chemico-Biological Interactions (2025), pp. 111489-111489
Open Access
Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: Implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant
Hussein maitham Qassim, Bagher Seyedalipour, Payam Baziyar, et al.
Computational Biology and Chemistry (2023) Vol. 107, pp. 107967-107967
Closed Access | Times Cited: 10
The Genetic Association of MMP-2 Gene Polymorphisms with the Susceptibility to Alzheimer's Disease
Lina Liu, Luran Liu, Yunting Lu, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 3, pp. 52-52
Open Access | Times Cited: 3
Prenylated Flavanone Isolated from Dalea Species as a Potential Multitarget-Neuroprotector in an In Vitro Alzheimer’s Disease Mice Model
María Daniela Santi, Diego B. Carvalho, Rosina Dapueto, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 3
Flavonoid–Phenolic Acid Hybrids Are Potent Inhibitors of Ferroptosis via Attenuation of Mitochondrial Impairment
Madeline Günther, Samentha Dabare, Jennifer Fuchs, et al.
Antioxidants (2023) Vol. 13, Iss. 1, pp. 44-44
Open Access | Times Cited: 7
American Ginseng for the Treatment of Alzheimer’s Disease: A Review
Mengyao Shan, Yunfan Bai, Xiaoxue Fang, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5716-5716
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top